RhumbLine Advisers’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$121M Sell
315,230
-11,996
-4% -$4.6M 0.1% 164
2025
Q1
$113M Buy
327,226
+13,142
+4% +$4.54M 0.11% 160
2024
Q4
$94.3M Sell
314,084
-9,565
-3% -$2.87M 0.08% 190
2024
Q3
$132M Sell
323,649
-431
-0.1% -$175K 0.12% 142
2024
Q2
$104M Sell
324,080
-10,827
-3% -$3.48M 0.1% 168
2024
Q1
$112M Sell
334,907
-24,849
-7% -$8.29M 0.11% 163
2023
Q4
$97.4M Sell
359,756
-12,942
-3% -$3.5M 0.1% 175
2023
Q3
$91.7M Sell
372,698
-5,168
-1% -$1.27M 0.11% 161
2023
Q2
$115M Sell
377,866
-1,591
-0.4% -$483K 0.13% 134
2023
Q1
$100M Sell
379,457
-3,162
-0.8% -$834K 0.12% 149
2022
Q4
$91.8M Buy
382,619
+8,099
+2% +$1.94M 0.12% 156
2022
Q3
$68.8M Buy
374,520
+30,414
+9% +$5.59M 0.1% 180
2022
Q2
$57.8M Sell
344,106
-97
-0% -$16.3K 0.08% 214
2022
Q1
$86.3M Buy
344,203
+4,987
+1% +$1.25M 0.11% 159
2021
Q4
$87.2M Buy
339,216
+1,374
+0.4% +$353K 0.11% 162
2021
Q3
$82M Sell
337,842
-21,033
-6% -$5.11M 0.11% 156
2021
Q2
$74.2M Sell
358,875
-34,380
-9% -$7.11M 0.1% 175
2021
Q1
$74.1M Sell
393,255
-33,739
-8% -$6.35M 0.1% 170
2020
Q4
$70.2M Sell
426,994
-47,683
-10% -$7.84M 0.1% 174
2020
Q3
$59.2M Sell
474,677
-9,650
-2% -$1.2M 0.09% 186
2020
Q2
$47M Buy
484,327
+13,795
+3% +$1.34M 0.08% 220
2020
Q1
$42.3M Buy
470,532
+27,080
+6% +$2.43M 0.09% 203
2019
Q4
$65.5M Sell
443,452
-11,659
-3% -$1.72M 0.11% 176
2019
Q3
$54.8M Buy
455,111
+5,477
+1% +$660K 0.1% 198
2019
Q2
$60.8M Buy
449,634
+25,094
+6% +$3.39M 0.11% 175
2019
Q1
$55.4M Buy
424,540
+7,441
+2% +$970K 0.11% 179
2018
Q4
$51.9M Buy
417,099
+6,676
+2% +$831K 0.11% 169
2018
Q3
$57.1M Sell
410,423
-12,170
-3% -$1.69M 0.11% 185
2018
Q2
$43.4M Sell
422,593
-10,587
-2% -$1.09M 0.09% 218
2018
Q1
$42M Sell
433,180
-8,385
-2% -$813K 0.09% 229
2017
Q4
$38.8M Buy
441,565
+9,754
+2% +$857K 0.08% 257
2017
Q3
$34.4M Sell
431,811
-3,382
-0.8% -$269K 0.07% 271
2017
Q2
$37.9M Sell
435,193
-3,633
-0.8% -$317K 0.09% 244
2017
Q1
$39.1M Buy
438,826
+13,914
+3% +$1.24M 0.09% 231
2016
Q4
$31.5M Buy
424,912
+23,355
+6% +$1.73M 0.08% 263
2016
Q3
$30.4M Buy
401,557
+13,321
+3% +$1.01M 0.08% 245
2016
Q2
$29.9M Buy
388,236
+10,636
+3% +$819K 0.09% 233
2016
Q1
$29.5M Buy
377,600
+21,571
+6% +$1.68M 0.09% 224
2015
Q4
$24.1M Sell
356,029
-3,821
-1% -$258K 0.08% 253
2015
Q3
$27.8M Buy
359,850
+22,835
+7% +$1.77M 0.09% 216
2015
Q2
$30.6M Buy
337,015
+4,761
+1% +$432K 0.1% 214
2015
Q1
$25M Buy
332,254
+127,879
+63% +$9.62M 0.07% 254
2014
Q4
$15M Buy
204,375
+11,980
+6% +$879K 0.04% 377
2014
Q3
$13.6M Sell
192,395
-428
-0.2% -$30.2K 0.04% 391
2014
Q2
$10.9M Buy
192,823
+24,415
+14% +$1.38M 0.03% 465
2014
Q1
$8.84M Sell
168,408
-6,075
-3% -$319K 0.03% 545
2013
Q4
$8.33M Sell
174,483
-13,054
-7% -$623K 0.02% 568
2013
Q3
$8.02M Sell
187,537
-120
-0.1% -$5.13K 0.02% 592
2013
Q2
$6.77M Buy
+187,657
New +$6.77M 0.02% 639